These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
334 related items for PubMed ID: 16094446
1. Epigenetic silencing of the MGMT gene in cancer. Soejima H, Zhao W, Mukai T. Biochem Cell Biol; 2005 Aug; 83(4):429-37. PubMed ID: 16094446 [Abstract] [Full Text] [Related]
2. Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer. Nakagawachi T, Soejima H, Urano T, Zhao W, Higashimoto K, Satoh Y, Matsukura S, Kudo S, Kitajima Y, Harada H, Furukawa K, Matsuzaki H, Emi M, Nakabeppu Y, Miyazaki K, Sekiguchi M, Mukai T. Oncogene; 2003 Dec 04; 22(55):8835-44. PubMed ID: 14647440 [Abstract] [Full Text] [Related]
7. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Esteller M, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Watkins DN, Issa JP, Sidransky D, Baylin SB, Herman JG. Cancer Res; 2000 May 01; 60(9):2368-71. PubMed ID: 10811111 [Abstract] [Full Text] [Related]
10. O(6)-Methylguanine-DNA methyltransferase promoter hypermethylation shifts the p53 mutational spectrum in non-small cell lung cancer. Wolf P, Hu YC, Doffek K, Sidransky D, Ahrendt SA. Cancer Res; 2001 Nov 15; 61(22):8113-7. PubMed ID: 11719438 [Abstract] [Full Text] [Related]
11. Hypermethylation of O6-methylguanine-DNA methyltransferase promoter may predict nonrecurrence after chemotherapy in colorectal cancer cases. Nagasaka T, Sharp GB, Notohara K, Kambara T, Sasamoto H, Isozaki H, MacPhee DG, Jass JR, Tanaka N, Matsubara N. Clin Cancer Res; 2003 Nov 01; 9(14):5306-12. PubMed ID: 14614014 [Abstract] [Full Text] [Related]
12. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers. Koga Y, Kitajima Y, Miyoshi A, Sato K, Kitahara K, Soejima H, Miyazaki K. Ann Surg Oncol; 2005 May 01; 12(5):354-63. PubMed ID: 15915369 [Abstract] [Full Text] [Related]
13. Promoter hypermethylation and inactivation of O(6)-methylguanine-DNA methyltransferase in esophageal squamous cell carcinomas and its reactivation in cell lines. Fang MZ, Jin Z, Wang Y, Liao J, Yang GY, Wang LD, Yang CS. Int J Oncol; 2005 Mar 01; 26(3):615-22. PubMed ID: 15703815 [Abstract] [Full Text] [Related]
14. Hypermethylation of the DNA repair gene MGMT: association with TP53 G:C to A:T transitions in a series of 469 nervous system tumors. Bello MJ, Alonso ME, Amiñoso C, Anselmo NP, Arjona D, Gonzalez-Gomez P, Lopez-Marin I, de Campos JM, Gutierrez M, Isla A, Kusak ME, Lassaletta L, Sarasa JL, Vaquero J, Casartelli C, Rey JA. Mutat Res; 2004 Oct 04; 554(1-2):23-32. PubMed ID: 15450401 [Abstract] [Full Text] [Related]
18. MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. Kaina B, Christmann M, Naumann S, Roos WP. DNA Repair (Amst); 2007 Aug 01; 6(8):1079-99. PubMed ID: 17485253 [Abstract] [Full Text] [Related]